|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 27/62 | |
| G01N 33/15 | |||
| G01N 33/50 | |||
| G01N 33/53 | |||
| C12Q 1/02 |
| (11) | Number of the document | 3213062 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15856119.1 |
| Date of filing the European patent application | 2015-10-29 | |
| (97) | Date of publication of the European application | 2017-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/057963 |
| Date | 2015-10-29 |
| (87) | Number | WO 2016/069847 |
| Date | 2016-05-06 |
| (30) | Number | Date | Country code |
| 201462073320 P | 2014-10-31 | US |
| (72) |
WOOLF, Clifford J., US
LATINI, Alexandra S., US
ANDREWS, Nick A., US
LATREMOLIERE, Alban, US
COSTIGAN, Michael, US
|
| (73) |
Children`s Medical Center Corporation,
55 Shattuck Street, Boston, MA 02115,
US
|
| (54) | METHODS AND ASSAYS RELATING TO SEPIAPTERIN REDUCTASE INHIBITION |
| METHODS AND ASSAYS RELATING TO SEPIAPTERIN REDUCTASE INHIBITION |